OTCMKTS:CNTMFCansortium Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cansortium Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.32 -0.05 (-13.51 %) (As of 07/6/2020 04:00 PM ET) Add Compare Share Today's Range$0.32Now: $0.32▼$0.3750-Day Range$0.32MA: $0.36▼$0.4152-Week Range$0.05Now: $0.32▼$1.75Volume4,230 shsAverage Volume54,097 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlinesSocial Media Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. It operates cultivation, processing, and dispensary facilities in Florida, Texas, and Puerto Rico; and a dispensary license in Pennsylvania. The company was founded in 2015 and is headquartered in Miami, Florida.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingCansortium has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $0.70, Cansortium has a potential upside of 118.8% from its current price of $0.32.Amount of Analyst CoverageCansortium has only been the subject of 1 research reports in the past 90 days. Previous Next 1.9 Community Rank Outperform VotesCansortium has received 17 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCansortium has received 27 “underperform” votes. (Add your “underperform” vote.)Community SentimentCansortium has received 61.36% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Cansortium and other stocks. Vote “Outperform” if you believe CNTMF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CNTMF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCansortium does not currently pay a dividend.Dividend GrowthCansortium does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cansortium insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.5Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.08 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CNTMF Previous Symbol CUSIPN/A CIKN/A Webwww.cansortium.com Phone305-902-2720Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:CNTMF Rates by TradingView Receive CNTMF News and Ratings via Email Sign-up to receive the latest news and ratings for CNTMF and its competitors with MarketBeat's FREE daily newsletter. Cansortium (OTCMKTS:CNTMF) Frequently Asked Questions How has Cansortium's stock been impacted by COVID-19 (Coronavirus)? Cansortium's stock was trading at $0.22 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CNTMF shares have increased by 45.5% and is now trading at $0.32. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Cansortium? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cansortium in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Cansortium. What price target have analysts set for CNTMF? 1 brokerages have issued 1-year target prices for Cansortium's stock. Their forecasts range from $0.70 to $0.70. On average, they anticipate Cansortium's stock price to reach $0.70 in the next year. This suggests a possible upside of 118.8% from the stock's current price. View analysts' price targets for Cansortium. Has Cansortium been receiving favorable news coverage? News headlines about CNTMF stock have trended negative on Monday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cansortium earned a daily sentiment score of -2.1 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news about Cansortium. Who are some of Cansortium's key competitors? Some companies that are related to Cansortium include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannara Biotech (LOVE), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF), CLS Holdings USA (CLSH) and Cosmos (COSM). View all competitors. Who are Cansortium's key executives? Cansortium's management team includes the following people: Mr. Jose Javier Hidalgo, CEO & DirectorMr. Henry Batievsky, CFO & DirectorMr. Patrick Maloy, COO & DirectorDr. Jennifer McCafferty-Fernandez, Chief Science OfficerMr. Jeffrey Reath, Exec. VP of Fin. & Investor Relations Corp. Sec. and Director What is Cansortium's stock symbol? Cansortium trades on the OTCMKTS under the ticker symbol "CNTMF." How do I buy shares of Cansortium? Shares of CNTMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Cansortium's stock price today? One share of CNTMF stock can currently be purchased for approximately $0.32. What is Cansortium's official website? The official website for Cansortium is www.cansortium.com. How can I contact Cansortium? The company can be reached via phone at 305-902-2720. This page was last updated on 7/6/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
